Stoke Therapeutics Inc (STOK)
NASDAQ
Fin d'année 31 Décembre 2023 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -455.761 | -22.77 | -19.225 | -19.839 | -31.97 | -40.841 | -43.228 |
Return on Equity (%) | 860.372 | -24.131 | -19.621 | -20.467 | -34.059 | -50.204 | -60.798 |
Return on Invested Capital (%) | 824.036 | -24.694 | -21.683 | -20.798 | -34.215 | -51.985 | -66.869 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | -814.728 | -1192.472 |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | -814.728 | -1192.472 |
Book Value Per Share | -0.195 | 0.451 | 0.868 | 1.091 | 0.83 | 0.697 | 0.59 |
Earnings Per Share | -0.834 | -0.054 | -0.125 | -0.199 | -0.327 | -0.381 | -0.387 |
Cash Per Share | 0.27 | 0.453 | 0.861 | 1.096 | 0.552 | 0.428 | 0.708 |
Working Capital Per Share | -0.271 | 0.445 | 0.859 | 1.078 | 0.808 | 0.802 | 0.683 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | 0.047 | 0.032 |
EBIT Per Share | -0.834 | -0.054 | -0.125 | -0.199 | -0.327 | -0.381 | -0.387 |
EBITDA Per Share | -0.834 | -0.054 | -0.125 | -0.199 | -0.327 | -0.381 | -0.387 |
Free Cash Flow Per Share | -0.834 | -0.051 | -0.12 | -0.199 | -0.326 | -0.372 | -0.391 |
Fin d'année 31 Décembre 2023 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 6,67M | 7,24M | 32,86M | 36,58M | 36,9M | 39,44M | N/A |
Fin d'année 31 Décembre 2023 | Sept 2022 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
Actions en circulation | 39,43M | 39,44M | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | -437.597 | N/A | N/A | N/A | -625.569 | N/A |
Net Profit Margin (%) | N/A | N/A | -437.597 | N/A | N/A | N/A | -625.569 | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 561,45M |
Ratio cours/bénéfice | -5,37 |
Ratio prix/ventes | 63,99 |
Ratio prix/liquidités | 2,94 |
Ratio prix/valeur comptable | 3,52 |
Rendement de dividende | - |
Actions en circulation | 52,97M |
Volume moyen (1 semaine) | 596,42k |
Volume moyen (1 mois) | 870,17k |
Variation sur 52 semaines | 111,13% |
Plus haut sur 52 semaines | 17,58 |
Plus bas sur 52 semaines | 4,09 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales